Table 4

Prognostic impact of CXCR4 and other prognostic variables on overall survival and relapse-free survival

VariableUnivariate
Multivariate
HR95% CIPHR95% CIP
Overall survival* 
    CXCR4 MFIR 2.699 1.327-5.489 .006 2.007 1.044-3.858  .037 
    LDH level 2.436 1.152-5.151 .02 — — — 
    Unfavorable cytogenetics 2.182 1.146-4.154 .018 2.478 1.129-5.441  .024 
Relapse-free survival 
    CXCR4 MFIR 3.853 1.298-11.442 .015 3.853 1.298-11.442 .015 
    WBC count 0.315 0.124-0.802 .015 — — — 
    Unfavorable cytogenetics 2.283 0.986-5.286 .054 — — — 
VariableUnivariate
Multivariate
HR95% CIPHR95% CIP
Overall survival* 
    CXCR4 MFIR 2.699 1.327-5.489 .006 2.007 1.044-3.858  .037 
    LDH level 2.436 1.152-5.151 .02 — — — 
    Unfavorable cytogenetics 2.182 1.146-4.154 .018 2.478 1.129-5.441  .024 
Relapse-free survival 
    CXCR4 MFIR 3.853 1.298-11.442 .015 3.853 1.298-11.442 .015 
    WBC count 0.315 0.124-0.802 .015 — — — 
    Unfavorable cytogenetics 2.283 0.986-5.286 .054 — — — 

In this analysis, CXCR4 MFIR values were analyzed as a numeric variable without grouping into low, intermediate, or high expression (groups A to C).

HR indicates hazard ratio; CI, confidence interval; —, not applicable.

*

n = 90.

n = 60.

Close Modal

or Create an Account

Close Modal
Close Modal